With new, stricter FDA regulations and guidelines in place, the world of pharmaceutical sales has been turned on its ear. We’re seeing a whole lot less “Wild, Wild West” and a whole lot more “Brave New World.”

Everybody is scrambling, trying to adapt. At the very same time, sales forces are being slashed, sometimes by as much as two-thirds. Pharmaceutical companies are being forced to rethink strategies for reaching physicians. Some are spending mind-boggling amounts on direct-to-consumer marketing campaigns attempting to push patients to request specific brand names and hopefully, persuade their physicians to prescribe accordingly.

At Technekes, we know there’s a more effective and efficient approach.

We know – from experience – that you can outsource some of those sales responsibilities to stop the hemorrhaging of key physician accounts as well as continue to service important physicians who may otherwise be dropped from circulation, due to internal sales force cuts. Using highly intelligent external resources, we can even help you efficiently pick up “unattended” physicians, sustaining “conversations of value” in geographic areas that no other sales force is reaching.

We’re already seeing great success with this methodology, which keeps your external sales force focused on key deciles, while still meeting sales objectives in lower deciles.

Sure, it takes a bold client to make this kind of change, but we figure that a brave, new world is going to be populated with brave, new clients. Wouldn’t you agree?